Does TORIPALIMAB Cause Hypertriglyceridaemia? 19 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Hypertriglyceridaemia have been filed in association with TORIPALIMAB (LOQTORZI). This represents 1.4% of all adverse event reports for TORIPALIMAB.
19
Reports of Hypertriglyceridaemia with TORIPALIMAB
1.4%
of all TORIPALIMAB reports
8
Deaths
0
Hospitalizations
How Dangerous Is Hypertriglyceridaemia From TORIPALIMAB?
Of the 19 reports, 8 (42.1%) resulted in death, and 3 (15.8%) were considered life-threatening.
Is Hypertriglyceridaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TORIPALIMAB. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does TORIPALIMAB Cause?
Myelosuppression (590)
Off label use (276)
White blood cell count decreased (144)
Anaemia (67)
Hypothyroidism (67)
Neutrophil count decreased (67)
Nausea (60)
Rash (59)
Vomiting (58)
Platelet count decreased (53)
What Other Drugs Cause Hypertriglyceridaemia?
PEGASPARGASE (399)
VINCRISTINE (373)
METHOTREXATE (372)
DEXAMETHASONE (358)
CYTARABINE (244)
CYCLOPHOSPHAMIDE (191)
QUETIAPINE (181)
MERCAPTOPURINE (176)
PREDNISONE (161)
DAUNORUBICIN (143)
Which TORIPALIMAB Alternatives Have Lower Hypertriglyceridaemia Risk?
TORIPALIMAB vs TORSEMIDE
TORIPALIMAB vs TOVIAZ
TORIPALIMAB vs TOVORAFENIB
TORIPALIMAB vs TOZINAMERAN
TORIPALIMAB vs TRABECTEDIN